SEC Form 4 · accession 0001513162-15-000329
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Berman
Officer — President and CEO · Director
Period of report
Jun 9, 2015
Accepted (ET)
Jun 10, 2015 · 4:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 9, 2015 | P | 10,000 | $0.1399 | A | 688,650 | D | |
| Common Stock | Jun 10, 2015 | P | 10,000 | $0.1449 | A | 698,650 | D |
Table II — derivative securities
No Table II lines on this filing.